Carson Wealth (CWM LLC)’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.3K Sell
3,678
-15
-0.4% -$289 ﹤0.01% 3623
2025
Q4
$49K Buy
3,693
+1,053
+40% +$9.33K ﹤0.01% 3630
2025
Q3
$16K Buy
2,640
+212
+9% +$993 ﹤0.01% 4254
2025
Q2
$10K Buy
2,428
+2,346
+2,861% +$9.45K ﹤0.01% 4325
2025
Q1
$0 Buy
+82
New +$379 ﹤0.01% 5239

Other funds holding BIOA

Carson Wealth (CWM LLC)'s BIOA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its BioAge Labs (BIOA) stake by 0.41% in Q1 2026, selling an estimated $289 and leaving 3,678 shares worth $64.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3623.

Carson Wealth (CWM LLC) first reported a position in BIOA in Q1 2025 and has held it in 5 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 3,678 shares of BioAge Labs worth $64.3K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 15 BioAge Labs shares in Q1 2026, an estimated $289.
  • BioAge Labs made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3623 holding.
  • Carson Wealth (CWM LLC) first reported a position in BioAge Labs in Q1 2025 and has held it in 5 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.